Stay updated on Nivolumab in Salivary Gland Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Salivary Gland Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Salivary Gland Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH notice says federal agencies are transitioning to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), and that both terms may appear during the transition.
    Difference
    1%
    Check dated 2026-10-25T13:23:22.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T13:27:07.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1 on the error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:11:07.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Access to the study record now shows a 403 Forbidden error page with the site header and footer. This blocks display of the study details and navigation that would normally appear on the record page.
    Difference
    18%
    Check dated 2026-09-20T19:53:55.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Adds a funding/identification line '2016 ( U.S. NIH Grant/Contract )' to the study record. Updates the site revision to 'Revision: v3.6.6', replacing the previous 'Revision: v3.6.5'.
    Difference
    0.1%
    Check dated 2026-08-30T22:19:47.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.6.5 is shown in place of v3.6.4, indicating a backend update that does not alter the study information on the page.
    Difference
    0.1%
    Check dated 2026-08-09T11:24:00.000Z thumbnail image

Stay in the know with updates to Nivolumab in Salivary Gland Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Salivary Gland Carcinoma Clinical Trial page.